Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on LinkedIn:
“Honored to chair the ‘Malignant Hematology session’ alongside our amazing team in collaboration with Binaytara – great discussions and shared learning advancing patient care.”
Binay Shah, Co-Founder, President and CEO at Binaytara, shared Al-Ola Abdallah’s post, adding:
“Outstanding session. Excellent panel”
More posts featuring Al-Ola Abdallah.